An overview of the global pharmaceutical logistics market Keeping pharmaceutical products undamaged and therapeutically effective during their journey to the market can often prove to be an arduous and complex task. Once outside the sterile manufacturing and packaging...
Identifying Key Regenerative Medicine Manufacturing Challenges
Regenerative medicines are currently the hive of innovation in modern science with far-reaching benefits for big pharma, healthcare systems, and patient outcomes. We can expect a rapid pace of development in the US regenerative medicine market over the next decade....
Winning in Emerging Markets: What Big Pharma Companies Must Do
Emerging markets are highly promising and offer a plethora of opportunities for pharmaceutical companies. As a result, there is an unprecedented increase in the number of companies in the life sciences industry that are turning to emerging markets such as Brazil,...
Pharmaceutical Market Research: A Linchpin for Success in the Pharma Industry
Pharmaceutical companies are experiencing an industry slowdown. Amidst this, many players in the sector are seeking to transform their R&D engine into a source of competitive advantage in order to thrive. In such cases, effective pharmaceutical market research is...
Pharmaceutical Industry Challenges to Watch Out for in 2019
Despite several major challenges in the way over the past couple of years, the pharmaceutical industry continues to thrive. However, the sector is not completely free from challenges this year either. Due to the nature of the industry, cost aspects and stricter...
4 Factors You Should Consider Before Investing in Emerging Markets
Emerging markets have been on the path of rapid growth since the early 2000s. These markets are characterized by enormous growth potential that makes them a profitable place to invest in. However, the risks involved in investing in emerging markets are sometimes...
Emerging Markets – The Next Pharma Challenge
There was a time when the EU5 nations (Spain, UK, Italy, France, and Germany) were regarded as the hot spots by pharma majors. But as the developing countries increased investments in the healthcare sector, pharma manufacturers see immense potential in these markets...